Is Lexaria Bioscience Stock a Good Investment?
Lexaria Bioscience Investment Advice | LEXXW |
- Examine Lexaria Bioscience's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Lexaria Bioscience's leadership team and their track record. Good management can help Lexaria Bioscience navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Lexaria Bioscience's business and its evolving consumer preferences.
- Compare Lexaria Bioscience's performance and market position to its competitors. Analyze how Lexaria Bioscience is positioned in terms of product offerings, innovation, and market share.
- Check if Lexaria Bioscience pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Lexaria Bioscience's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Lexaria Bioscience Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Lexaria Bioscience Corp is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Lexaria Bioscience Stock
Researching Lexaria Bioscience's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if Lexaria Bioscience is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Lexaria Bioscience's research are outlined below:
| Lexaria Bioscience generated a negative expected return over the last 90 days | |
| Lexaria Bioscience has high historical volatility and very poor performance | |
| Lexaria Bioscience has some characteristics of a very speculative penny stock | |
| Lexaria Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 464.28 K. Net Loss for the year was (5.81 M) with profit before overhead, payroll, taxes, and interest of 494.2 K. | |
| Lexaria Bioscience Corp has accumulated about 1.31 M in cash with (4.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Lexaria Bioscience's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 33.79 M.Basic technical analysis of Lexaria Stock
As of the 26th of March, Lexaria Bioscience secures the Risk Adjusted Performance of (0.03), standard deviation of 14.4, and Mean Deviation of 10.31. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lexaria Bioscience Corp, as well as the relationship between them. Please verify Lexaria Bioscience Corp coefficient of variation and the relationship between the information ratio and kurtosis to decide if Lexaria Bioscience Corp is priced some-what accurately, providing market reflects its recent price of 0.33 per share. As Lexaria Bioscience Corp appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.Lexaria Bioscience's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Lexaria Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Lexaria Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Lexaria Bioscience insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Understand Lexaria Bioscience's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Lexaria Bioscience's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.58) | |||
| Mean Deviation | 10.31 | |||
| Coefficient Of Variation | (2,397) | |||
| Standard Deviation | 14.4 | |||
| Variance | 207.33 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.61) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | (0.59) | |||
| Maximum Drawdown | 61.17 | |||
| Value At Risk | (23.08) | |||
| Potential Upside | 25.93 | |||
| Skewness | 0.3996 | |||
| Kurtosis | 0.7614 |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.58) | |||
| Mean Deviation | 10.31 | |||
| Coefficient Of Variation | (2,397) | |||
| Standard Deviation | 14.4 | |||
| Variance | 207.33 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.61) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | (0.59) | |||
| Maximum Drawdown | 61.17 | |||
| Value At Risk | (23.08) | |||
| Potential Upside | 25.93 | |||
| Skewness | 0.3996 | |||
| Kurtosis | 0.7614 |
Consider Lexaria Bioscience's intraday indicators
Lexaria Bioscience intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Lexaria Bioscience stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Lexaria Bioscience time-series forecasting models is one of many Lexaria Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Lexaria Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Lexaria Stock media impact
Far too much social signal, news, headlines, and media speculation about Lexaria Bioscience that are available to investors today. That information is available publicly through Lexaria media outlets and privately through word of mouth or via Lexaria internal channels. However, regardless of the origin, that massive amount of Lexaria data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lexaria Bioscience news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lexaria Bioscience relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lexaria Bioscience's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lexaria Bioscience alpha.
Lexaria Bioscience Corporate Management
| Christopher Bunka | Chairman CEO | Profile | |
| Vanessa Carle | Head Legal | Profile | |
| Philip Ainslie | Advisor Consultant | Profile | |
| Nelson CPA | Chief Officer | Profile | |
| MS MD | Chief Board | Profile | |
| Richard Christopher | Chief Officer | Profile |
Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.